Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion type Assertion NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_head.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion evidence source_evidence_literature NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion SIO_000772 15598955 NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion wasDerivedFrom befree-20150227 NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.
- NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_assertion wasGeneratedBy ECO_0000203 NP812588.RAOMOYLfHH6go22_ZEQ3FLFMJfH9fnngg5OB9bUmsElNk130_provenance.